The Dylan Gemelli PodcastEpisode #111 Featuring Dr. Elizabeth Yurth and Dr. Robin Rose! The MOST COMPREHENSIVE Functional Medicine Interview! SGLT2 inhibitors, GLP-1's, Plasmalogens, Neuroplasticity, Covid dangers and more!Will SGLT2s Go Mainstream?
15:52–16:29 · 37s
Yurth predicts SGLT2 inhibitors won’t catch on like GLP-1s because they lack dramatic weight loss, despite broad longevity benefits.